[1] |
ZHU Jingna, MO Huihui, LIANG Yanhua.
Fluorescent staining to identify fungal cloning in the healthy skin and inflammatory lesions
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(2): 83-88.
|
[2] |
ZHOU Xiaonan, GAO Yingxia, CAO Chunyan, WANG Fang, YANG Zhengqian.
Effect of therapeutic games based on Satya model on hospitalized children with psoriasis and their parents
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(2): 122-127.
|
[3] |
LIU Chengling, HE Zan, REN Dan, WANG Jingyu, DU Zhimin, SUN Yufa, ZHAO Hua.
Association of psoriasis and psoriatic arthritis with ulcerative colitis: a meta-analysis
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 8-13.
|
[4] |
WANG Na, LIU Hong, WU Weizhi, ZHANG Zhaoxia, ZHOU Guizhi, SHI Zhongxiang, ZHANG Furen.
TNF-α antagonist combined with immunoglobulin in the treatment of herpes virus-related chronic relapsing erythema multiforme: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 34-36.
|
[5] |
ZENG Zhen, QI Jue, ZHAO Yueting, GENG Wenjin, LIU Tongyun.
Chondroma cutis on the anterior neck: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 47-48.
|
[6] |
WANG Juanjuan, YIN Xingping, SUN Linan, GAO Yuan, LU Xiaojun, LIU Wei.
Psoriasis complicated with arsenate keratosis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 51-53.
|
[7] |
HE Zhendan, XIAO Yizhu.
Clinic analysis of 75 chiliren with severe drug eruption
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(9): 561-564.
|
[8] |
LIU Li, TAN Jing, HE Xigetu, WANG Bailing, QI Baopeng, GUO Jingxue, MU Qiri.
Cutaneous mastocytosis in children characterized by mastocytoma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(9): 599-601.
|
[9] |
SUN Weina, LI Yuzhen.
Update of treatment for erythrodermic psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(9): 614-617.
|
[10] |
REN Guohua, ZHAO Ying.
Effects of total glucosides of paeony combined with NB-UVB on the expression of serum IL-17, IL-23 and lesion PAR-2 in patients with moderate to severe psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 506-509.
|
[11] |
LU Wenhua, GUO Jia, CAO Duling, ZHU Wu.
Recombinant human tumor necrosis factor receptor type II-IgG Fc fusion protein with glucocorticoid successfully treat Stevens-Johnson syndrome: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 525-527.
|
[12] |
HU Zhonghui, SUN Qing.
Update of biological agents in the treatment of psoriasis comorbidities
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(7): 471-476.
|
[13] |
LOU Yanfeng, ZHOU Xiaowei, LIU Fang, KONG Qingtao, CHEN Jun, YANG Yang.
Analysis of relapsing factors in psoriasis vulgaris and study on self-management intervention
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(6): 376-379.
|
[14] |
SUN Jie, WANG Rui, HUANG Min, BAI Jia, LI Chengxin.
Effect of IL-17A on insulin resistance in keratinocytes
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 271-275.
|
[15] |
LU Changpei, YANG Qinghua, YU Biao, WANG Runchao, BU Qingyun, JING Haixia.
Clinicopathological analysis of 15 cases with glomus tumor
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 301-304.
|